Search results
Pfizer’s first gene therapy gets approval for clotting disorder
San Francisco Chronicle· 3 days agoPfizer Inc. won US approval for its first gene therapy, expanding into a promising field of medicine that has proved to be a challenging business. The treatment, called Beqvez ...
What Factors Will Drive Pfizer's Q1 Performance?
Forbes· 4 days agoWe expect the company to post revenue of $13.8 billion and earnings of $0.50 on a per share and adjusted basis.
3 Ultra-Yield Dividend Stocks Retirees Can Trust
247wallst.com· 4 hours agoDividends are a major part of an investor’s complete return profile. By the same token, retirees don’t want to leave potential returns on the table,...
Pfizer and Levi Strauss Face Challenges from Conservative Shareholders Over Support of Divisive...
National Center for Public Policy Research· 5 days agoWashington, D.C. – At this week’s Pfizer and Levi Strauss annual shareholder meetings, shareholder...
Pfizer Receives FDA Approval for Bleeding Disorder Treatment
Barrons.com· 3 days agoPfizer has received approval from the Food and Drug Administration for a rare genetic bleeding...
Pfizer's Options: A Look at What the Big Money is Thinking - Pfizer (NYSE:PFE)
Benzinga· 3 days agoLoading... Loading... Deep-pocketed investors have adopted a bullish approach towards Pfizer PFE , and it's something market players shouldn't ignore. Our tracking of public ...
FDA approves Pfizer's first gene therapy for rare inherited bleeding disorder
NBC Philadelphia· 3 days agoThe Food and Drug Administration approved Pfizer's treatment for a rare genetic bleeding disorder,...
Pfizer Wins FDA Approval For $3.5 Million Gene Therapy
Investor's Business Daily· 3 days agoPfizer won FDA approval for a new hemophilia B gene therapy, a rival to Hemgenix from CSL and Uniqure.
What's Going On With Pfizer Stock On Thursday? - GSK (NYSE:GSK), Pfizer (NYSE:PFE)
Benzinga· 4 days agoGSK Plc GSK has reportedly taken legal action against Pfizer Inc PFE and BioNTech SE BNTX in a...
Pfizer's Beqvez, which is given as a single intravenous infusion, was shown in a clinical trial of...
Homenewshere.com· 3 days agoPfizer's Beqvez, which is given as a single intravenous infusion, was shown in a clinical trial of 45 people to be better at preventing bleeding among adults with moderate to